A new federal study will look at whether a medication many people know for weight management could also help veterans who are working to change their relationship with alcohol.

In late July 2026, the U.S. Department of Veterans Affairs began recruiting veterans for a clinical trial that is drawing significant attention. The study will test whether semaglutide, a GLP-1 medication, can help treat alcohol use disorder. It's one of the largest efforts yet to explore a question researchers have been asking for a few years now: could a class of drugs developed for diabetes and weight management also reduce the pull of alcohol?

For the more than 400,000 veterans currently diagnosed with alcohol use disorder, the trial is a hopeful sign that treatment options are still growing, and that a condition too often surrounded by stigma is getting serious scientific attention.

What the trial involves

The VA study, known as the Cessation or Reduction of Alcohol Consumption in Veterans trial, is enrolling more than 600 veterans between the ages of 18 and 80 who have moderate or severe alcohol use disorder. Participants receive weekly injections of semaglutide over 24 weeks, followed by a safety follow-up period. The research is running at 18 VA medical centers across the country, in states including Michigan, North Carolina, Illinois, Utah, Georgia, Ohio, Texas, California, Florida, Oregon, Pennsylvania, and Wisconsin.

Throughout the study, researchers will track changes in drinking patterns, health outcomes, and quality of life to see whether semaglutide offers a meaningful new option. VA Secretary Doug Collins described the trial as "medical research that VA is uniquely situated to launch," aimed directly at benefiting veterans.

The interest isn't coming out of nowhere. Earlier in 2026, an analysis of more than 600,000 U.S. veterans published in The BMJ found that people taking GLP-1 medications had lower rates of alcohol use disorder and other substance use disorders than similar patients on different diabetes drugs. That kind of signal is what a controlled clinical trial can help confirm.

Sean Simler, Military Operations and Transformation Lead at SonderMind, shared his reaction to the research: "This genuinely surprised me! I knew there was early science on GLP-1s lowering the risk of Alzheimer's and dementia, but I had no idea they might help with alcohol use too. I guess if these drugs can suppress the urge to eat, it tracks that they could do the same with the urge to drink. This could be a real breakthrough for the many veterans who struggle with alcoholism, and I'm really curious what the results of this study will be."

Why this matters for veterans

Alcohol use disorder affects roughly 11% of U.S. adults and often shows up alongside other mental health conditions. For veterans, alcohol can become closely tied to post-traumatic stress, depression, anxiety, and the adjustment back to civilian life. 

That's part of why more treatment options matter. For some veterans, therapy is enough on its own. Others do better with a combination of medication and counseling. FDA-approved medications for alcohol use disorder, such as naltrexone and acamprosate, are already available, and if research eventually adds GLP-1s to that list, it would give providers and patients one more option to consider together.

Alcohol use disorder is treatable, and help is available now. If you or a veteran you love has been thinking about the role alcohol plays in daily life, you can talk with a licensed provider about what support might look like.

FAQs about GLP-1s and alcohol use disorder

Is semaglutide approved to treat alcohol use disorder?
No. Semaglutide is currently approved for other uses, and its potential role in alcohol use disorder is still being studied. The VA trial is one of the efforts working to answer that question.

How would a GLP-1 help with drinking?
Researchers think GLP-1 medications may influence the brain's reward and craving pathways, which could reduce the urge to drink. The trial is designed to test whether that translates into real, measurable changes for veterans.

What are the current treatment options for alcohol use disorder?
Evidence-based options include therapy, FDA-approved medications like naltrexone and acamprosate, and peer support programs. Care works best when it's tailored to the individual, and it often addresses other mental health conditions at the same time.